Document Detail


Oxygen therapy for patients with COPD: current evidence and the long-term oxygen treatment trial.
MedLine Citation:
PMID:  20605816     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Long-term use of supplemental oxygen improves survival in patients with COPD and severe resting hypoxemia. However, the role of oxygen in symptomatic patients with COPD and more moderate hypoxemia at rest and desaturation with activity is unclear. The few long-term reports of supplemental oxygen in this group have been of small size and insufficient to demonstrate a survival benefit. Short-term trials have suggested beneficial effects other than survival in patients with COPD and moderate hypoxemia at rest. In addition, supplemental oxygen appeared to improve exercise performance in small short-term investigations of patients with COPD and moderate hypoxemia at rest and desaturation with exercise, but long-term trials evaluating patient-reported outcomes are lacking. This article reviews the evidence for long-term use of supplemental oxygen therapy and provides a rationale for the National Heart, Lung, and Blood Institute Long-term Oxygen Treatment Trial. The trial plans to enroll subjects with COPD with moderate hypoxemia at rest or desaturation with exercise and compare tailored oxygen therapy to no oxygen therapy.
Authors:
James K Stoller; Ralph J Panos; Samuel Krachman; Dennis E Doherty; Barry Make;
Related Documents :
9558016 - Comparison of three protocols for breathing exercises during immersion in 38 degrees c ...
17238666 - Exercise and symptom monitoring with a mobile device.
20087706 - Exertional dyspnea-related acidotic and sympathetic responses in patients with sequelae...
10731326 - Quantitative 15 steps exercise oximetry as a marker of disease severity in patients wit...
12929236 - Alterations in the mechanical properties of the human chondrocyte pericellular matrix w...
2574496 - The importance of potassium and lactate for maximal exercise performance during beta bl...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review    
Journal Detail:
Title:  Chest     Volume:  138     ISSN:  1931-3543     ISO Abbreviation:  Chest     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-07-07     Completed Date:  2010-08-17     Revised Date:  2011-08-01    
Medline Journal Info:
Nlm Unique ID:  0231335     Medline TA:  Chest     Country:  United States    
Other Details:
Languages:  eng     Pagination:  179-87     Citation Subset:  AIM; IM    
Affiliation:
Respiratory Institute, Department of Pulmonary and Critical Care Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Follow-Up Studies
Humans
Oxygen Inhalation Therapy / methods*
Pulmonary Disease, Chronic Obstructive / therapy*
Randomized Controlled Trials as Topic*
Time Factors
Treatment Outcome
Grant Support
ID/Acronym/Agency:
HHSN268200736183C//PHS HHS; HHSN268200736184C//PHS HHS; HHSN268200736186C//PHS HHS; HHSN268200736187C//PHS HHS; HHSN268200736188C//PHS HHS; HHSN268200736189C//PHS HHS; HHSN268200736190C//PHS HHS; HHSN268200736191C//PHS HHS; HHSN268200736192C//PHS HHS; HHSN268200736193C//PHS HHS; HHSN268200736194C//PHS HHS; HHSN268200736195C//PHS HHS; HHSN268200736196C//PHS HHS; HHSN268200736197C//PHS HHS; HSN268200736185C//PHS HHS; Y1-HR-7019-01/HR/NHLBI NIH HHS; Y1-HR-8076-01/HR/NHLBI NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Responsibility for quality improvement and patient safety: hospital board and medical staff leadersh...
Next Document:  International classification of disease coding for obstructive lung disease: does it reflect appropr...